Lupin receives USFDA approval for Brimonidine Tartrate Ophthalmic Solution, 0.1%
Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The product is bioequivalent and therapeutically equivalent to the reference listed drug
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Travoprost Ophthalmic Solution USP, 0.004%, is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Acetazolamide is used to treat glaucoma
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The new facility will be able to handle four times as many patients as the previous facility.
Subscribe To Our Newsletter & Stay Updated